Climate Change Data

EKF Diagnostics Holdings plc

Climate Impact & Sustainability Data (2021, 2022, 2023)

Reporting Period: 2021

Environmental Metrics

Total Carbon Emissions:15 tCO2e (UK only)
Scope 1 Emissions:1 tCO2e (UK only)
Scope 2 Emissions:14 tCO2e (UK only)
Total Energy Consumption:68,468 kWh (electricity) + 2,017 kWh (transport) (UK only)
Carbon Intensity:0.18 tonnes of CO2 per £m of turnover (UK only)

ESG Focus Areas

  • Environment
  • Social
  • Governance

Environmental Achievements

  • Reduced CO2 emissions to 15 tonnes (0.18 tonnes per £m turnover) in the UK. Note: This is only for UK operations and doesn't represent the entire company's emissions.

Social Achievements

  • Donation of products to selected charities.
  • Encouragement of staff participation in charitable activities.
  • Contribution to local communities.
  • Publication of Modern Slavery Act statement on website.
  • Regular briefing of employees on Group activities.
  • Monitoring of staff attrition rates and competitive compensation.

Governance Achievements

  • Adoption of the Corporate Governance Code issued by the Quoted Company Alliance.
  • Establishment of Audit and Remuneration Committees.
  • Board evaluation of performance and effectiveness of Board committees.

Climate Goals & Targets

Medium-term Goals:
  • Significant revenue growth in Life Sciences by 2024 through enzyme production capacity expansion.

Environmental Challenges

  • Retention of key employees.
  • Political risk, particularly in Russia due to sanctions.
  • Supply chain continuity issues.
  • Regulatory risk (IVDR in EU and MHRA in UK).
  • Competition risk from larger multinational companies.
  • Intellectual property risk.
  • Foreign exchange risk.
  • Reimbursement levels from third-party payers.
  • Financial reporting and disclosure.
  • Cyber security risk.
  • Pandemic risk (COVID-19).
  • Plastic packaging tax in the UK.
Mitigation Strategies
  • Incentivisation packages for key employees.
  • Diversification of revenue streams geographically.
  • Close dialogue with key suppliers and monitoring inventory.
  • Adaptation to IVDR and MHRA requirements.
  • Patent registration protection, confidentiality agreements, monitoring technological developments, and strong distribution partners.
  • Developing products where patent protection is available, maintaining confidentiality agreements, and monitoring technological developments.
  • Matching currency receipts and expenditure, and negotiating currency protection in contracts.
  • Constant dialogue and education of third-party payers, and development of new technologies.
  • Internal controls over financial information and reporting, and external audits.
  • Robust security measures, staff training, and back-up systems.
  • Plans to mitigate disruption, including remote working and increased supplier/customer contact.
  • Increased knowledge of the tax and systems to measure its effect.

Supply Chain Management

Climate-Related Risks & Opportunities

Transition Risks
  • Increased regulatory requirements from customers regarding net-zero initiatives.
  • Potential for reductions in asset values or higher costs due to a greener economy.

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:337,989 tCO2e/year
Scope 1 Emissions:21,351 tCO2e/year
Scope 2 Emissions:316,658 tCO2e/year
Total Energy Consumption:1,526,111 Kwh/year
Carbon Intensity:0.19 tonnes of CO2 per £m of turnover

ESG Focus Areas

  • Environment
  • Social
  • Governance

Environmental Achievements

  • Reduced energy usage through wastage and promoting video conferencing.

Social Achievements

  • Donated product to selected charities; encouraged staff participation in charitable activities; maintained competitive staff compensation levels to attract and retain high-caliber personnel; conducted an Employee Engagement Survey.

Governance Achievements

  • Adopted the Corporate Governance Code for Small and Mid-Size Quoted Companies from The Quoted Companies Alliance; established a formal and transparent procedure for developing policy on executive remuneration; implemented a system of internal control to provide reasonable assurance regarding the reliability of financial information.

Climate Goals & Targets

Environmental Challenges

  • Longer than anticipated transition to non-COVID revenues in Contract Manufacturing and Laboratory Testing; underperformance in Contract Manufacturing and Laboratory Testing; rapid reduction in the market for COVID-related products; political risk in Russia; regulatory risk related to IVDR; cybersecurity risk; pandemic risk; climate change risks (physical and transitional); plastic packaging tax.
Mitigation Strategies
  • Cost reduction, restructuring, and operational efficiency measures; closure of UK Contract Manufacturing operation; disposal of ADL Health; frequent communications with senior management in Russia; diversified revenue streams geographically; monitoring events and taking mitigating actions; securing patent registration protection; maintaining confidentiality agreements; working with experienced distribution partners; adapting to IVDR requirements; robust security measures, staff training, and back-up systems; monitoring events and taking mitigating actions; increasing knowledge of plastic packaging tax and introducing systems to measure its effect; securing a committed £3m of funding from North Atlantic Smaller Companies Investment Trust.

Supply Chain Management

Climate-Related Risks & Opportunities

Physical Risks
  • Severe weather events
Transition Risks
  • Increased regulatory requirements from customers; move towards a greener economy; reductions in asset values or higher costs of doing business.

Reporting Standards

Frameworks Used: QCA Code

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:473 tCO2e/year (Group)
Total Energy Consumption:1,822,783 Kwh/year (Group)

ESG Focus Areas

  • Climate Change
  • Employee Wellbeing
  • Corporate Social Responsibility

Environmental Achievements

  • Reduced carbon emissions per £m of turnover to 0.18 tonnes of CO2 (2022: 0.19 tonnes of CO2). Improved energy efficiency by reducing electricity usage through lower wastage and promoting video conferencing.

Social Achievements

  • Donated product to selected charities. Encouraged staff participation in charitable activities. Maintained competitive staff compensation levels to attract and retain high-calibre personnel. Closely monitored staff attrition rates.
  • Applications for employment by disabled persons are always fully considered.

Governance Achievements

  • Adopted the Corporate Governance Code for Small and Mid-Size Quoted Companies from The Quoted Companies Alliance (the “QCA Code”). Implemented a Senior Management team with a proven track record for delivery.

Climate Goals & Targets

Medium-term Goals:
  • Scale up output for fermentation customers and add additional customers. Aiming to have South Bend site running at closer to optimal capacity by early 2026.
Short-term Goals:
  • Continue to implement strategies to grow Point-of-Care and Life Sciences and to concentrate on core products and services within each of the divisions to drive further margin improvement and enhance cash generation.

Environmental Challenges

  • Increasing raw material and other costs.
  • Increased competition from India and China in clinical chemistry.
  • Declining sales and increased technical challenges in STAT-Site M β-HB serum and plasma product line.
  • Reduced revenues from Russia due to increased sanctions.
  • Impact of sanctions and Russian Government retaliation on Russian operations.
Mitigation Strategies
  • Consolidated product offering to focus on higher margin products and services.
  • Discontinued non-core, low-margin products (clinical chemistry range and STAT-Site M β-HB).
  • Opened upgraded Life Sciences facility in South Bend to improve downstream processing and attract new customers.
  • Reduced revenue expectations from Russia.
  • Diversified revenue streams geographically with a mixture of distribution partners in developing and developed countries.
  • Cost savings made and the disposal of ADL Health, and a lower headcount across the other businesses.

Supply Chain Management

Climate-Related Risks & Opportunities

Physical Risks
  • Severe weather events
Transition Risks
  • Increased regulatory requirements from customers regarding net zero initiatives.
  • Potential reductions in asset values or higher costs of doing business due to a move towards a greener economy.

Reporting Standards

Frameworks Used: QCA Code